Suppr超能文献

与代偿期肝硬化患者和健康对照组相比,失代偿期肝硬化患者的肠道转运时间较慢。

Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls.

机构信息

*Department of Medicine, Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD †Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine ‡Yale School of Public Health, Yale Center of Analytical Science, New Haven, CT §University Medical Center of Princeton, Princeton, NJ.

出版信息

J Clin Gastroenterol. 2013 Nov-Dec;47(10):888-93. doi: 10.1097/MCG.0b013e31829006bb.

Abstract

BACKGROUND

Altered small intestinal motility in cirrhotics may play a major role in the development of bacterial translocation (BT) by leading to small intestinal bacterial overgrowth. BT has been implicated in the development of several complications including spontaneous bacterial peritonitis, esophageal variceal hemorrhage, and hepatorenal syndrome. Prior studies using antroduodenal manometry to evaluate intestinal motility have shown discrepancies regarding the relationship between dysmotility and the severity of cirrhosis.

OBJECTIVES

(1) To characterize the frequency of small bowel motility disturbances in cirrhotic patients using a wireless motility capsule (SmartPill); (2) To assess the relationship of intestinal dysmotility with liver disease severity and cirrhosis complications; and (3) To compare intestinal transit times and motility indices among cirrhotics and healthy controls.

METHODS

We conducted a prospective study of 20 patients with cirrhosis (10 compensated, 10 decompensated) who were recruited from Yale New Haven Hospital and Hepatology clinics (February 2011 to July 2011). All patients underwent and completed SmartPill studies. Intestinal transit times were calculated, analyzed, and compared among compensated versus decompensated cirrhotics versus historical, healthy controls. Intestinal transit delays/motility indices were correlated with disease severity and complications.

RESULTS

Decompensated cirrhotics had significantly longer small bowel transit times (SBTT) as compared with compensated cirrhotics (6.17 vs. 3.56 h, P=0.036). There was a significant correlation (r=0.77, P=0.0003) between SBTT and cirrhosis severity as assessed by Child-Pugh score. There were no statistical differences noted between the groups for gastric or colonic transit times, although there was a trend toward prolonged transit throughout the gut in decompensated. Cirrhotics with spontaneous bacterial peritonitis and ascites also had significantly longer SBTT as compared with those without.

CONCLUSIONS

This study demonstrates that decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls. Additional prospective studies are needed to further characterize dysmotility in cirrhotics and its relationship to complications related to BT. This would aid in the identification of patients at risk for developing severe complications and who may benefit from prophylactic prokinetic and/or antimicrobial therapy.

摘要

背景

肝硬化患者的小肠运动改变可能通过导致小肠细菌过度生长而在细菌易位(BT)的发展中起主要作用。BT 与多种并发症的发展有关,包括自发性细菌性腹膜炎、食管静脉曲张出血和肝肾综合征。先前使用抗十二指肠测压法评估肠道运动的研究表明,动力障碍与肝硬化严重程度之间的关系存在差异。

目的

(1)使用无线动力胶囊(SmartPill)描述肝硬化患者小肠运动障碍的频率;(2)评估肠道动力障碍与肝病严重程度和肝硬化并发症的关系;(3)比较肝硬化患者和健康对照组的肠道转运时间和动力指数。

方法

我们对 20 例来自耶鲁纽黑文医院和肝脏病学诊所的肝硬化患者(10 例代偿性,10 例失代偿性)进行了前瞻性研究(2011 年 2 月至 2011 年 7 月)。所有患者均完成了 SmartPill 研究。计算、分析和比较了代偿性与失代偿性肝硬化患者与历史健康对照组之间的肠道转运时间。肠道转运延迟/动力指数与疾病严重程度和并发症相关。

结果

与代偿性肝硬化患者相比,失代偿性肝硬化患者的小肠转运时间(SBTT)明显更长(6.17 小时对 3.56 小时,P=0.036)。SBTT 与 Child-Pugh 评分评估的肝硬化严重程度之间存在显著相关性(r=0.77,P=0.0003)。两组之间的胃或结肠转运时间无统计学差异,尽管失代偿组的肠道转运时间有延长趋势。自发性细菌性腹膜炎和腹水的肝硬化患者的 SBTT 也明显长于无这些并发症的患者。

结论

本研究表明,与代偿性肝硬化患者和健康对照组相比,失代偿性肝硬化患者的肠道转运时间较慢。需要进一步的前瞻性研究来进一步描述肝硬化患者的动力障碍及其与 BT 相关并发症的关系。这将有助于确定发生严重并发症风险较高的患者,并可能受益于预防性促动力和/或抗菌治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验